|Bid||1.60 x 1200|
|Ask||2.85 x 800|
|Day's Range||2.25 - 2.68|
|52 Week Range||1.63 - 7.93|
|PE Ratio (TTM)||0.12|
|Earnings Date||Nov 27, 2017 - Dec 1, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.00|
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that struck 52-week highs on Sept. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ...
COPENHAGEN, Denmark, Sept. 19, 2018-- Forward Pharma A/S, today reported consolidated financial results for the six-month period ended June 30, 2018. Net loss for the six-month period ended June 30, 2018 ...
Forward Pharma A/S (FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the LSX Nordic Congress being held August 29-30, 2018 in Stockholm, Sweden. Dr. Svendsen will present a corporate update on Thursday, August 30, 2018 at 15.15 CET and will be available for one-on-one meetings. A recording of the presentation will be made available through the Company’s website.
NEW YORK, NY / ACCESSWIRE / May 23, 2018 / U.S. markets fell Tuesday on geopolitical concerns after President Trump stated he was not happy with the current U.S. – China trade talks. The Dow Jones Industrial ...
Stocks, such as SandRidge Mississippian Trust I and Hudson Technologies, are trading at a value below what they may actually be worth. There’s a few ways you can determine howRead More...
Research Desk Line-up: Forward Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / October 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for AVEO ...